Authors


Ebtesam Ahmed, PharmD, MS

Latest:

Antidepressants in Patients With Advanced Cancer: When They’re Warranted and How to Choose Therapy

In this article, we discuss the importance of screening for depression in cancer patients, as well as the available treatment options and their pros and cons.


Austin Lunney, BS

Latest:

Incidental Primary Squamous Cell Carcinoma of the Kidney Within a Calyceal Diverticulum Associated With Nephrolithiasis

A 64-year-old man is diagnosed with primary squamous cell carcinoma within the upper pole calyceal diverticulum of the kidney. What are the best steps of management?


Irfan Warraich, MD

Latest:

Incidental Primary Squamous Cell Carcinoma of the Kidney Within a Calyceal Diverticulum Associated With Nephrolithiasis

A 64-year-old man is diagnosed with primary squamous cell carcinoma within the upper pole calyceal diverticulum of the kidney. What are the best steps of management?


Joerg Herrmann, MD

Latest:

Detecting Cardiotoxicity in Cancer Patients Receiving VEGF Inhibitors

Dr. Herrmann discusses how to monitor and treat cardiotoxicity in cancer patients receiving VEGF inhibitors.


Reid Thompson, MD, PhD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Adam Dicker, MD, PhD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Sanjay Aneja, MD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Benjamin H. Kann, MD

Latest:

Artificial Intelligence in Oncology: Current Applications and Future Directions

In this review, we introduce the fundamentals of artificial intelligence and provide an overview of its current applications, pitfalls, and future directions in oncology.


Mehmet Sitki Copur, MD, FACP

Latest:

Leveraging Community Setting Multidisciplinary Care in Pancreatic Cancer

Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.


Shaila Merchant, MD

Latest:

Using Genetics to Determine Disparities in Gastric Cancer

Cancer Network spoke with Dr. Shaila Merchant about the difficulty in determining and linking the many disparities in gastric cancer and how genetic research can help.


Richard Gray, MSc

Latest:

Prolong Adjuvant Aromatase Inhibitor Therapy in Breast Cancer?

Cancer Network spoke with Richard Gray, MSc, about the effects of prolonging adjuvant aromatase inhibitor therapy has on breast cancer patients.


Gwendolyn Thomas

Latest:

Exercise Effects on Depressive Symptoms in Cancer Patients

Cancer Network speaks with an exercise physiologist about the benefits of physical activity for depressed and anxious cancer patients. 


Maggie Bedillion

Latest:

Exercise Effects on Depressive Symptoms in Cancer Patients

Cancer Network speaks with an exercise physiologist about the benefits of physical activity for depressed and anxious cancer patients. 


Joseph Unger, PhD, MS

Latest:

Decreasing Clinical Trial Participation Barriers

Cancer Network speaks with Joseph Unger, PhD, about ways to decrease the barriers for cancer patients to enroll in clinical trials.


Derek A. Wainwright, PhD

Latest:

Newly Diagnosed Glioblastoma: A Review on Clinical Management

This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.


Erik Ladomersky, PhD

Latest:

Newly Diagnosed Glioblastoma: A Review on Clinical Management

This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.


Adam M. Sonabend, MD

Latest:

Newly Diagnosed Glioblastoma: A Review on Clinical Management

This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.


Erin Schenk, MD, PhD

Latest:

New Developments in Neoadjuvant Therapy for Lung Cancer

In this article, we review the new developments in neoadjuvant therapy for lung cancer.


Jose Pacheco, MD

Latest:

New Developments in Neoadjuvant Therapy for Lung Cancer

In this article, we review the new developments in neoadjuvant therapy for lung cancer.


Anastasios Dimou, MD

Latest:

New Developments in Neoadjuvant Therapy for Lung Cancer

In this article, we review the new developments in neoadjuvant therapy for lung cancer.


Bryden Considine, DO

Latest:

Novel Targets and Precision Medicine for Prostate Cancer-Part 2: Tumor Profiling and Personalized Therapy in Patients With Castration-Resistant Prostate Cancer

In this article, we review the current use of and future direction for genetic testing and tumor profiling in patients with metastatic castration-resistant prostate cancer.


Alexandria M. Hertz, MD

Latest:

A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal Mass

A 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?


Timothy C. Brand, MD

Latest:

A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal Mass

A 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?


Matthew M. Banti, MD

Latest:

A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal Mass

A 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?


Sean Sachdev, MD

Latest:

Newly Diagnosed Glioblastoma: A Review on Clinical Management

This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.


Charles Shapiro, MD

Latest:

Role of Chemopreventive Agents in Women at Increased Risk for Breast Cancer

Cancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.


Amber Draper, PharmD, BCOP

Latest:

Regorafenib for Metastatic Colorectal Cancer: Common Toxicities and Prevention Strategies

An oncology pharmacist discusses how to prevent and treat the toxicities from regorafenib for the treatment of colorectal cancer.


Katherinee Morales-Chacón, MD

Latest:

Multiple Myeloma With Extramedullary Disease: A Challenging Clinical Dilemma

A 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?


Deborah Martínez-Baños, MD, PhD

Latest:

Multiple Myeloma With Extramedullary Disease: A Challenging Clinical Dilemma

A 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?


Jesús Delgado-de-la-Mora, MD

Latest:

Multiple Myeloma With Extramedullary Disease: A Challenging Clinical Dilemma

A 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?